Bio-Connect

CD3 antibody [OKT3] (PerCP-Cy5.5)

Research Use Only
GTX79906-11
GeneTex
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman, Primate
TargetCD3D
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CD3 antibody [OKT3] (PerCP-Cy5.5)
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody recognizes the CD3 antigen of the TCR/CD3 complex on mature human T cells. This antibody, also known as Orthoclone OKT3 or Muromonab-CD3, has been extensively used as a drug for therapy of acute, glucocorticoid resistant rejection of allogen
  • Application Supplier Note
    FACS: 0.25 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    OKT3
  • Concentration
    0.05 mg/ml
  • Conjugate
    Double Conjugated
  • Formulation
    Liquid
  • Gene ID915
  • Target name
    CD3D
  • Target description
    CD3d molecule
  • Target synonyms
    CD3 antigen, delta subunit; CD3 delta; CD3d antigen, delta polypeptide (TiT3 complex); CD3d molecule, delta (CD3-TCR complex); CD3-DELTA; IMD19; OKT3, delta chain; T3D; T-cell receptor T3 delta chain; T-cell surface glycoprotein CD3 delta chain
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDP04234
  • Protein Name
    T-cell surface glycoprotein CD3 delta chain
  • Reactivity
    Human, Primate
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients. Zhang C et al., 2021 Dec, J Surg Oncol
    Read more
  • Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab. Zheng G et al., 2021 Jun 23, Signal Transduct Target Ther
    Read more
  • Contribution of ROS and metabolic status to neonatal and adult CD8+ T cell activation. Sanchez-Villanueva JA et al., 2019, PLoS One
    Read more
  • STAT5B: A Differential Regulator of the Life and Death of CD4(+) Effector Memory T Cells. Majri SS et al., 2018 Jan 1, J Immunol
    Read more
  • Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity. Haga-Friedman A et al., 2012 Jun 1, J Immunol
    Read more
  • IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Ralpha. Bikker A et al., 2012 Jun, Rheumatology (Oxford)
    Read more
  • A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Bagnara D et al., 2011 May 19, Blood
    Read more
  • A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation. Nguyen V et al., 2009 Nov, Mol Cell Proteomics
    Read more
  • The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype. Bibollet-Ruche F et al., 2008 Oct, J Virol
    Read more
  • CD1a and CD1c activate intrathyroidal T cells during Graves disease and Hashimotos thyroiditis. Roura-Mir C et al., 2005 Mar 15, J Immunol
    Read more